Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Phase IIb adrenomyeloneuropathy study of RPI-78M cleared to begin

Oct. 10, 2006

Risperdal approved for irritability associated with autistic disorder

Oct. 9, 2006

Swedish approval for phase IIa study of PBT-2 in early Alzheimer's disease

Oct. 9, 2006

Traditional Indian phytotherapy shows potential in AD therapy

Oct. 9, 2006

Phase II study of MTR-106 for acute migraine without aura on schedule

Oct. 6, 2006

UCB and Jazz expand Xyrem license agreement to include fibromyalgia syndrome

Oct. 6, 2006

Data on Sativex in multiple sclerosis patients accumulates

Oct. 6, 2006

ONO-2506 active in experimental autoimmune encephalomyelitis models

Oct. 6, 2006

Canadian approval for Tysabri in relapsing-remitting MS

Oct. 5, 2006

Possible higher risk of cleft palate in babies exposed to Lamictal

Oct. 5, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...